Recorded Presentation from the NCCN Pharmacy Updates: New Cytotoxic and Targeted Therapies for Soft Tissue Sarcoma
Join Daniel Melzer, PharmD, BCOP from Moffitt Cancer Center for this webinar in the 2018 NCCN Pharmacy Update Webinar Series on the topic New Cytotoxic and Targeted Therapies for Soft Tissue Sarcoma.
Category
  • Soft Tissue Sarcomas
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Chronic Lymphocytic Leukemia (CLL)
Join Jennifer Brown, MD, PhD, and Matthew Davids, MD, MMSc, from Dana-Farber Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to chronic lymphocytic leukemia (CLL).
Category
  • Chronic Lymphocytic Leukemia
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Kidney Cancer
Join Toni Choueiri, MD, and Bradley McGregor, MD from Dana-Farber Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to kidney cancer.
Category
  • Kidney Cancer
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Neuroendocrine and Adrenal Tumors, Version 2.2018
The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET.
Category
  • Neuroendocrine Tumors
Format
  • Monograph/Journal Supplement
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Non–Small Cell Lung Cancer, Version 5.2018
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.
Category
  • Lung Cancers
Format
  • Monograph/Journal Supplement
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018 Nursing Program Webinar Series - Optimizing Oral Therapy in Kidney Cancer
Renal cell carcinoma (RCC) continues to have a significant health impact. With the emergence of these new therapies, it is increasingly important for oncology nurses to understand the data supporting all the available choices and the adverse effects associated with each of them.
Category
  • Kidney Cancer
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018 Nursing Program Webinar Series - Substance Use in Patients with Cancer
Despite the known negative impacts of substance misuse and abuse among patients with cancer, these issues often go undiagnosed and/or untreated in patients with cancer.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018 Nursing Program Webinar Series - Implementing a CAR T-Cell Therapy Program
Recent advances in immunotherapies are changing the standard of care for patients with cancer.
Category
  • Acute Lymphoblastic Leukemia
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018 Nursing Program Webinar Series - Management of Hypersensitivity Reactions to Systemic Therapy
Infusion-related HSR to systemic therapy is a serious adverse effect that significantly impacts disease management, quality of life, and life expectancy. Careful assessment of patients prior to initiating systemic therapy would enable the identification of patients at higher risk for HSR.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Treatment Considerations in Metastatic Melanoma
Join Cindy L. O’Bryant, PharmD, from the University of Colorado Cancer Center for this webinar in the 2018 NCCN Pharmacy Update Series on the topic Treatment Considerations in Metastatic Melanoma.
Category
  • Melanoma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages